COMMUNIQUÉS West-GlobeNewswire

Atrion Reports First Quarter Results

08/05/2019 - 22:30

ALLEN, Texas, May 08, 2019 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq - ATRI) today announced revenues for the quarter ended March 31, 2019 were $41.6 million compared with $39.4 million in the same period in 2018. [...]

LHC Group Announces First Quarter 2019 Financial Results

08/05/2019 - 22:30

Increases 2019 Guidance; Maintains Active M&A Pipeline LAFAYETTE, La., May 08, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced its financial results for the quarter ended March 31, 2019. Unless [...]

ADMA Biologics Reports First Quarter 2019 Financial Results

08/05/2019 - 22:18

RAMSEY, N.J. and BOCA RATON, Fla., May 08, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin [...]

CymaBay Reports First Quarter 2019 Financial Results and Provides Corporate Update

08/05/2019 - 22:05

Conference call and webcast today at 4:30p.m. ET NEWARK, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for [...]

Paratek’s NUZYRA™ (omadacycline) Generates Net Sales of $1.3 Million in the First Eight Weeks on the U.S. Market

08/05/2019 - 22:05

-- Approximately One Third of Commercial Lives in U.S. had Access to NUZYRA by the End of the First Quarter 2019 -- -- Significant Presence at ECCMID 2019 with Nine NUZYRA Presentations -- BOSTON, May 08, 2019 (GLOBE [...]

Dynavax Announces First Quarter 2019 Financial Results

08/05/2019 - 22:05

First quarter 2019 HEPLISAV-B® net product revenue of $5.6 million Conference call to be held today at 4:30 p.m. ET/1:30 p.m. PT BERKELEY, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation ( [...]

OrthoPediatrics Corp. Reports First Quarter 2019 Financial Results

08/05/2019 - 22:05

First Quarter 2019 Revenue Increased 21.2% Year-over-Year to $14.7 Million WARSAW, Ind., May 08, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), an orthopedic company focused [...]

Precision Optics Corporation Schedules Third Quarter Conference Call

08/05/2019 - 22:05

GARDNER, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) today announced that it intends to release its financial results for the fiscal year 2019 third quarter [...]

Sienna Biopharmaceuticals Reports First Quarter 2019 Financial Results

08/05/2019 - 22:05

-- Company Completed Positive End-of-Phase 2 Meeting with FDA for SNA-120 in Psoriasis WESTLAKE VILLAGE, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA) today reported the Company’ [...]

Akcea Reports Financial Results and Highlights for First Quarter 2019

08/05/2019 - 22:05

Achieved First Quarter 2019 TEGSEDI ® (inotersen) Global Net Product Revenues of $7 Million Novartis exercised its option to license AKCEA-APO(a)-L Rx Received marketing authorization for WAYLIVRA ® (volanesorsen) in E. [...]

GBT Reports Recent Business Progress and First Quarter 2019 Financial Results

08/05/2019 - 22:05

SOUTH SAN FRANCISCO, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today reported recent business progress and financial results for the first quarter ended March 31, 2019 [...]

Sienna Senior Living Inc. Reports 2019 First Quarter Financial Results

08/05/2019 - 22:05

MARKHAM, Ontario, May 08, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced its financial results for the three months ended March 31, 2019. The Unaudited [...]

Sarepta Therapeutics Announces First Quarter 2019 Financial Results and Recent Corporate Developments

08/05/2019 - 22:05

CAMBRIDGE, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the three months ended March [...]

Avid Bioservices Names Richard B. Hancock as Interim President and Chief Executive Officer

08/05/2019 - 22:05

Industry Veteran with Over 30 Years of Operational and Executive Experience Succeeds Roger J. Lias, Ph.D. TUSTIN, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated [...]

CV Sciences, Inc. Reports First Quarter 2019 Financial Results

08/05/2019 - 22:05

Record quarterly revenue Increased retail distribution by over 1,000 stores LAS VEGAS, May 08, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) ("CV Sciences" or the “Company”) announced today its financial [...]

Novavax Announces Reverse Stock Split of Common Stock

08/05/2019 - 22:05

GAITHERSBURG, Md., May 08, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced it will effect a one-for-twenty reverse stock split of its issued and outstanding common stock. Stockholders of Novavax [...]

SI-BONE, Inc. Reports First Quarter 2019 Financial Results

08/05/2019 - 22:05

SANTA CLARA, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for [...]

Intercept Pharmaceuticals Announces Proposed Offerings of $200 Million of Common Stock and $200 Million of Convertible Senior Notes due 2026

08/05/2019 - 22:05

NEW YORK, May 08, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral [...]

The Joint Corp. to Participate in Upcoming Investor Conferences

08/05/2019 - 22:05

SCOTTSDALE, Ariz., May 08, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced that management plans to present and conduct one-on-one [...]